POLE and neoplasm: Analysis of the functional differences between POLE mutant antigen-specific T cells and controls using the GSEA algorithm showed that POLEP286R-HLA-A*11:01-specific T cells significantly activated several tumor- and immune-related signaling pathways; the more significantly different pathways were those related to antigen presentation and processing, cytolysis and glycolysis (Figure 5D).